Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oncternal Therapeutics In...

    NASDAQ: ONCT · Real-Time Price · USD
    0.53
    -0.16 (-23.63%)
    At close: Dec 02, 2024, 10:00 PM

    Oncternal Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -39.48M -44.17M -31.33M
    Depreciation & Amortization
    		 n/a -75K 169K
    Stock-Based Compensation
    		 7.5M 7.43M 5.88M
    Other Working Capital
    		 3.04M -1.03M -2.12M
    Other Non-Cash Items
    		 -1.46M 179K 169K
    Deferred Income Tax
    		 n/a n/a -169K
    Change in Working Capital
    		 1.27M -69K -1.3M
    Operating Cash Flow
    		 -32.16M -36.7M -26.59M
    Capital Expenditures
    		 n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -64.35M -26.5M n/a
    Sales Maturities Of Investments
    		 65M n/a n/a
    Other Investing Acitivies
    		 n/a -26.5M n/a
    Investing Cash Flow
    		 651K -26.5M n/a
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 -156K -3K n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a 617K
    Financial Cash Flow
    		 1.07M 9.58M 617K
    Net Cash Flow
    		 -30.45M -53.62M -25.97M
    Free Cash Flow
    		 -32.16M -36.7M -26.59M

    Add to Watchlist